Interacciones de Acamprosato

Acamprosato (Campral) tiene 12 interacciones documentadas en las etiquetas de la FDA y las hojas informativas que indexamos. Graves: 0; moderadas: 0; leves: 1; casos en los que una etiqueta indica que no hay ninguna interacción significativa: 11. Cada entrada de abajo cita la frase que la respalda. Esta página del medicamento es un punto de partida, no un veredicto sobre su situación.

Qué aspecto tiene Acamprosato

Todas las versiones (6)
Acamprosato, tableta de 333 mg: blanca, redonda, 10 mm, con la inscripción 333.
333
333 mg · blanca · redonda · 10 mm
Carilion Materials Managem…
Acamprosato, tableta de 333 mg: blanca, redonda, 10 mm, con la inscripción 569.
569
333 mg · blanca · redonda · 10 mm
Zydus Pharmaceuticals (USA)
Acamprosato, tableta de 333 mg: blanca, redonda, 10 mm, con la inscripción 435.
435
333 mg · blanca · redonda · 10 mm
Glenmark Pharmaceuticals
Acamprosato, tableta de 333 mg: blanca, redonda, 10 mm, con la inscripción AC476.
AC476
333 mg · blanca · redonda · 10 mm
Somerset Therapeutics

Representaciones generadas a partir de los listados de productos de las etiquetas de la FDA: color, forma, tamaño e inscripción. 6 versiones documentadas de 7 etiquetadores.

Interacciones según la etiqueta

Menciones leves (1)

  • AlcoholAlcoholLeve

    Alcohol Withdrawal Use of acamprosate calcium does not eliminate or diminish withdrawal symptoms. (etiqueta de Acamprosato, Advertencias y precauciones)

Sin interacción significativa según la etiqueta (11)

  • Alvimopánantagonista opioideSin interacción

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (etiqueta de Acamprosato, Interacciones medicamentosas)

  • DiazepambenzodiazepinaSin interacción

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (etiqueta de Acamprosato, Interacciones medicamentosas)

  • Disulfiraminhibidor de CYP2C9Sin interacción

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (etiqueta de Acamprosato, Interacciones medicamentosas)

  • Metilnaltrexonaantagonista opioideSin interacción

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (etiqueta de Acamprosato, Interacciones medicamentosas)

  • Naldemedinaantagonista opioideSin interacción

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (etiqueta de Acamprosato, Interacciones medicamentosas)

  • Nalmefenoantagonista opioideSin interacción

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (etiqueta de Acamprosato, Interacciones medicamentosas)

  • Naloxegolantagonista opioideSin interacción

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (etiqueta de Acamprosato, Interacciones medicamentosas)

  • Naloxonaantagonista opioideSin interacción

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (etiqueta de Acamprosato, Interacciones medicamentosas)

  • Naltrexonaantagonista opioideSin interacción

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (etiqueta de Acamprosato, Interacciones medicamentosas)

  • Naltrexona y bupropiónantagonista opioideSin interacción

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (etiqueta de Acamprosato, Interacciones medicamentosas)

  • Pentazocina y naloxonaopioideSin interacción

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (etiqueta de Acamprosato, Interacciones medicamentosas)

Compruebe Acamprosato frente a todo lo que toma. Añada su lista completa; todos los pares se comprueban a la vez.

Abrir en el verificador

No es un consejo médico. La gravedad refleja la redacción de la etiqueta, no sus circunstancias. Una señal «grave» puede ser algo habitual bajo supervisión y una «leve» puede ser importante a dosis altas. Consulte a un farmacéutico.